General Information of Drug (ID:
DR0147) |
Drug Name |
Astemizole
|
Synonyms |
Alermizol; Astemisan; Astemison; Astemizol; Astemizol [German]; Astemizol [INN-Spanish]; Astemizolum; Astemizolum [INN-Latin]; GNF-PF-2461; Hestazol; Hismanal; Histamen; Histaminos; Histazol; Laridal; Metodih; Metodik; Novo-mastizol A; Paralergin; R 42512; R-43512; Retolen; Wareezol; Waruzol; astemizole; 1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine; 68844-77-9; BRN 4830190; C28H31FN4O; CCRIS 7595; EINECS 272-441-9; HSDB 6799; Kelp; UNII-7HU6337315
|
Indication |
Allergic rhinitis
[ICD11: CA08]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
458.6 |
Topological Polar Surface Area |
42.3 |
Heavy Atom Count |
34 |
Rotatable Bond Count |
8 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
5 |
Cross-matching ID |
- PubChem CID
- 2247
- PubChem SID
-
9050
; 459037
; 855746
; 4266413
; 5313663
; 7847301
; 7978732
; 8150150
; 8151518
; 10321136
; 11112828
; 11335214
; 11360453
; 11363342
; 11365904
; 11368466
; 11372003
; 11374824
; 11376628
; 11461425
; 11466164
; 11467284
; 11485540
; 11485887
; 11489548
; 11490887
; 11493037
; 11494262
; 11528621
; 11538010
; 12013338
; 14760289
; 22391432
; 26613163
; 26680817
; 26746979
; 26746980
; 26751496
; 26751497
; 29221421
; 46487928
; 46508569
; 47216611
; 47440072
; 47515146
; 47736292
; 47810587
; 47885241
; 48034934
; 48259050
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0Y2HR
- Formula
- C28H31FN4O
- Canonical SMILES
- COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
- InChI
- 1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
- InChIKey
- GXDALQBWZGODGZ-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.